81.84
Precedente Chiudi:
$85.09
Aprire:
$85.26
Volume 24 ore:
331.09K
Relative Volume:
3.08
Capitalizzazione di mercato:
$3.75B
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-5.21%
1M Prestazione:
-37.13%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Billiontoone Inc Stock (BLLN) Company Profile
Nome
Billiontoone Inc
Settore
Industria
Telefono
-
Indirizzo
-
Confronta BLLN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
BLLN
Billiontoone Inc
|
81.84 | 3.89B | 0 | 0 | 0 | 0.00 |
|
TMO
Thermo Fisher Scientific Inc
|
579.45 | 219.21B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
228.92 | 162.93B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
676.53 | 54.48B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
136.07 | 39.02B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
225.41 | 38.78B | 15.90B | 1.28B | 2.21B | 7.2842 |
Billiontoone Inc Stock (BLLN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-01 | Iniziato | BTIG Research | Buy |
| 2025-12-01 | Iniziato | JP Morgan | Overweight |
| 2025-12-01 | Iniziato | Jefferies | Hold |
| 2025-12-01 | Iniziato | Piper Sandler | Overweight |
| 2025-12-01 | Iniziato | Stifel | Buy |
| 2025-12-01 | Iniziato | Wells Fargo | Equal Weight |
| 2025-12-01 | Iniziato | William Blair | Outperform |
Mostra tutto
Billiontoone Inc Borsa (BLLN) Ultime notizie
Med-tech IPOs shoot for the stars in 2025 - BioWorld MedTech
BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference - 富途牛牛
BillionToOne stock in focus before Monday open after Friday jump, JPMorgan conference next - ts2.tech
BillionToOne (BLLN) Stock Update: Friday Rally, Analyst Price Targets, and the Next Catalysts Before Nasdaq Reopens - ts2.tech
BillionToOne Stock (NASDAQ: BLLN) News: Weekend Market Wrap, Analyst Targets, and What to Watch Before Monday’s Open - ts2.tech
BillionToOne Stock (NASDAQ: BLLN) Rises Into the Weekend as Analyst Targets Point Higher — What Investors Need to Know Before Monday - ts2.tech
Evommune and BillionToOne climb on trading debut - MSN
BillionToOne (BLLN) Is Down 6.7% After Joining the S&P Total Market IndexWhat's Changed - simplywall.st
BillionToOne: An Interesting Set-Up Into 2026 - Seeking Alpha
BillionToOne Stock (NASDAQ: BLLN) News, Forecasts, and Analyst Outlook for December 22, 2025 - ts2.tech
BillionToOne Adds Genmab CFO Anthony Pagano to Board, Names Him Audit Chair - TipRanks
Analysts Are Bullish on These Healthcare Stocks: Gilead Sciences (GILD), BillionToOne, Inc. Class A (BLLN) - The Globe and Mail
BillionToOne’s Earnings Call: Strong Growth and Strategic Outlook - TipRanks
BillionToOne, Inc. (NASDAQ:BLLN) Q3 2025 earnings call transcript - MSN
symbol__ Stock Quote Price and Forecast - CNN
Transcript : BillionToOne, Inc., Q3 2025 Earnings Call, Dec 09, 2025 - marketscreener.com
November reignites med-tech momentum with $4.7B raised - BioWorld MedTech
These Bay Area companies are IPO contenders in 2026 - The Business Journals
BillionToOne, Inc.: Strong Financial Performance and Strategic Market Positioning Drive Buy Rating - TipRanks
BillionToOne (BLLN) Revenue Surge Tests Bullish Growth Narrative Despite Ongoing EPS Losses - Sahm
BillionToOne, Inc.: Strong Financial Performance and Strategic Growth Initiatives Justify Buy Rating - TipRanks
BillionToOne, Inc. SEC 10-Q Report - TradingView — Track All Markets
BillionToOne price target lowered to $145 from $150 at JPMorgan - MSN
BillionToOne stock rating reiterated at Overweight by Piper Sandler - Investing.com South Africa
Jim Cramer Says BillionToOne Has a “Fantastic Story” Within the Diagnostics Space - MSN
BillionToOne Swings To Profit In Q3; Sees Q4 Revenue Soaring Up To 100% - Nasdaq
BillionToOne’s Strong Growth Potential and Strategic Integration Drive Buy Rating - TipRanks
BTIG Reiterates 'Buy' Rating for BillionToOne (BLLN) with PT of $160 | BLLN Stock News - GuruFocus
Earnings call transcript: BillionToOne’s strong Q3 2025 lifts stock 3.19% By Investing.com - Investing.com Nigeria
Billiontoone Q3 2025 Earnings Call Transcript - MarketBeat
BillionToOne Q3 2025 presentation slides: Revenue soars 117% as profitability achieved - Investing.com Canada
Earnings call transcript: BillionToOne’s strong Q3 2025 lifts stock 3.19% - Investing.com
Earnings call transcript: BillionToOne's strong Q3 2025 lifts stock 3.19% - Investing.com
BillionToOne appoints Genmab CFO Anthony Pagano to board - Investing.com
BillionToOne sees Q4 revenue $84M-$90M, consensus $80.14M - TipRanks
BillionToOne Appoints Anthony Pagano as Audit Chair - TipRanks
BillionToOne Q3 Swings to Profit, Revenue Rises; Shares Fall After Hours - marketscreener.com
BillionToOne appoints Genmab CFO Anthony Pagano to board By Investing.com - Investing.com Australia
BillionToOne reports Q3 EPS 10c, consensus 16c - TipRanks
BillionToOne Appoints Anthony Pagano to Board and Audit Committee - TradingView — Track All Markets
BillionToOne sees FY25 revenue $293M-$299M, consensus $288.61M - TipRanks
(BLLN) BillionToOne Expects Full Year 2025 Revenue Range $293M$299M, vs. FactSet Est of $288.6M - marketscreener.com
Earnings Flash (BLLN) BillionToOne Posts Q3 EPS $0.10, vs. FactSet Est of $0.14 - marketscreener.com
BillionToOne, Inc. Reports 117% Revenue Growth and Positive Operating Income in Q3 2025 - Quiver Quantitative
(BLLN) BillionToOne, Inc. Expects Q4 Revenue Range $84.0M$90.0M - marketscreener.com
Earnings Flash (BLLN) BillionToOne, Inc. Reports Q3 Revenue $83.5M, vs. FactSet Est of $82.9M - marketscreener.com
BillionToOne Reports Third Quarter 2025 Results - The Manila Times
BillionToOne Appoints Anthony Pagano to Board of Directors as Audit Committee Chair - StreetInsider
Billiontoone Inc Azioni (BLLN) Dati Finanziari
Non sono disponibili dati finanziari per Billiontoone Inc (BLLN). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):